Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ACAD

Acadia Pharmaceuticals Inc

May 26 • 04:00PM ET

21.26

+0.16 0.76 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: ALKS AXSM NBIX SUPN PRTA

| Held by: IJR VTI XBI VB IWM VBK VXF IBB SPSM IJT

Scroll to Statements

Index	RUT	P/E	9.68	EPS (ttm)	2.20	Insider Own	1.32%	Shs Outstand	171.09M	Perf Week	2.75%
Market Cap	3.64B	Forward P/E	27.66	EPS next Y	0.77	Insider Trans	-1.90%	Shs Float	168.98M	Perf Month	-3.19%
Enterprise Value	2.84B	PEG	-	EPS next Q	0.06	Inst Own	96.65%	Short Float	6.60%	Perf Quarter	-13.54%
Income	375.65M	P/S	3.32	EPS this Y	-83.08%	Inst Trans	0.01%	Short Ratio	6.05	Perf Half Y	-7.16%
Sales	1.10B	P/B	2.91	EPS next Y	97.54%	ROA	27.44%	Short Interest	11.16M	Perf YTD	-20.40%
Book/sh	7.29	P/C	4.28	EPS next 5Y	-14.50%	ROE	37.32%	52W High	28.35 -25.01%	Perf Year	-3.28%
Cash/sh	4.97	P/FCF	32.05	EPS past 3/5Y	- -	ROIC	29.19%	52W Low	19.69 7.97%	Perf 3Y	-14.21%
Dividend Est.	-	EV/EBITDA	30.63	Sales past 3/5Y	27.48% 19.39%	Gross Margin	91.47%	Volatility	3.00% 3.48%	Perf 5Y	-2.07%
Dividend TTM	-	EV/Sales	2.59	EPS Y/Y TTM	61.40%	Oper. Margin	7.39%	ATR (14)	0.73	Perf 10Y	-39.08%
Dividend Ex-Date	-	Quick Ratio	3.48	Sales Y/Y TTM	9.93%	Profit Margin	34.30%	RSI (14)	45.97	Recom	1.62
Dividend Gr. 3/5Y	- -	Current Ratio	3.59	EPS Q/Q	-81.36%	SMA20	-2.31%	Beta	0.84	Target Price	31.65
Payout	0.00%	Debt/Eq	0.04	Sales Q/Q	9.72%	SMA50	-2.10%	Rel Volume	0.50	Prev Close	21.10
Employees	798	LT Debt/Eq	0.03	Earnings	May 06 AMC	SMA200	-10.01%	Avg Volume	1.84M	Price	21.26
IPO	May 27, 2004	Option/Short	Yes / Yes	EPS/Sales Surpr.	-60.40% -4.34%	Trades		Volume	964,968	Change	0.76%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)